Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2012
Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study
Andrea Rachow, Petra Clowes, Elmar Saathoff, et al.
The Lancet. Microbe
|
October 13, 2023
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
Emmanuel Musisi, Adam Wyness, Sahar Eldirdiri, et al.
Plos One
|
July 9, 2011
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study
Andrea Rachow, Alimuddin Zumla, Norbert Heinrich, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosis
Patrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
BMC Medicine
|
March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2022
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse
Nyanda Elias Ntinginya, Abhishek Bakuli, Daniel Mapamba, et al.
PLOS Global Public Health
|
March 24, 2023
User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)-a qualitative study in Malawi and Zambia
Yannis Herrmann, Federica Lainati, María Del Mar Castro, et al.
PLOS Global Public Health
|
March 31, 2025
Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings
Edson Tawanda Marambire, Claire J Calderwood, Leyla Larsson, et al.
Plos One
|
November 27, 2013
miRNA signatures in sera of patients with active pulmonary tuberculosis
Paolo Miotto, Grace Mwangoka, Ilaria C Valente, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Ruth Bowness, Martin J Boeree, Rob Aarnoutse, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2012
Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study
Andrea Rachow, Petra Clowes, Elmar Saathoff, et al.
The Lancet. Microbe
|
October 13, 2023
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
Emmanuel Musisi, Adam Wyness, Sahar Eldirdiri, et al.
Plos One
|
July 9, 2011
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study
Andrea Rachow, Alimuddin Zumla, Norbert Heinrich, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosis
Patrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
BMC Medicine
|
March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2022
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse
Nyanda Elias Ntinginya, Abhishek Bakuli, Daniel Mapamba, et al.
PLOS Global Public Health
|
March 24, 2023
User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)-a qualitative study in Malawi and Zambia
Yannis Herrmann, Federica Lainati, María Del Mar Castro, et al.
PLOS Global Public Health
|
March 31, 2025
Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings
Edson Tawanda Marambire, Claire J Calderwood, Leyla Larsson, et al.
Plos One
|
November 27, 2013
miRNA signatures in sera of patients with active pulmonary tuberculosis
Paolo Miotto, Grace Mwangoka, Ilaria C Valente, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Ruth Bowness, Martin J Boeree, Rob Aarnoutse, et al.
Page
of 9